Your browser doesn't support javascript.
loading
Mechanisms of prion protein aggregation.
Fontaine, Sarah N; Brown, David R.
Afiliación
  • Fontaine SN; Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.
Protein Pept Lett ; 16(1): 14-26, 2009.
Article en En | MEDLINE | ID: mdl-19149668
The prion protein is a cell surface glycoprotein that is converted to a protease resistant abnormal isoform during the course of prion disease. The normal isoform of this protein has been shown to be an antioxidant that aids the survival of neurones. The abnormal isoform is associated with both the transmissible agent of prion diseases and is also toxic. Recent studies have shown that there are multiple end states in terms of aggregation of the protein. Both soluble oligomers and insoluble fibrils can form from the abnormal isoform. Although fibrils are characteristic of the disease, the most infectious prions are associated with oligomers. Neurotoxicity can be associated with fibrils but mostly appears to be due to small aggregates. For many years fibrils were believed to be central to the disease process but currently evidence supports the notion that fibrils represent a "bulk" form of abnormal protein, which is largely inert, but carried along a small active component. This review will examine what is known about the mechanisms behind prion protein aggregation, and the relevance of each form for the disease.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas PrPC Límite: Humans Idioma: En Revista: Protein Pept Lett Asunto de la revista: BIOQUIMICA Año: 2009 Tipo del documento: Article Pais de publicación: Países Bajos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas PrPC Límite: Humans Idioma: En Revista: Protein Pept Lett Asunto de la revista: BIOQUIMICA Año: 2009 Tipo del documento: Article Pais de publicación: Países Bajos